Skip to main content
Livermore
Livermore
ZHEN

HCR Wealth Advisors

SEC CIK
0001697715
Latest filing
Jul 13, 2026

EDIT holding history

Editas Medicine, Inc. in every 13F filed by HCR Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EDIT overviewAll 13F holders of EDITFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of EDIT by HCR Wealth Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−17,000−100.0%Sold outHolders
Q4 202517,000$34.9K<0.1%00.0%UnchangedHolders
Q3 202517,000$66.1K<0.1%00.0%UnchangedHolders
Q2 202517,000$37.4K<0.1%00.0%UnchangedHolders
Q1 202517,000$19.7K<0.1%00.0%UnchangedHolders
Q4 202417,000$21.6K<0.1%00.0%UnchangedHolders
Q3 202417,000$58.0K<0.1%00.0%UnchangedHolders
Q2 202417,000$79.4K<0.1%00.0%UnchangedHolders
Q1 202417,000$126.1K<0.1%−5,000−22.7%ReducedHolders
Q4 202322,000$222.9K<0.1%00.0%UnchangedHolders
Q3 202322,000$171.6K<0.1%00.0%UnchangedHolders
Q2 202322,000$181.1K<0.1%00.0%UnchangedHolders
Q1 202322,000$159.5K<0.1%00.0%UnchangedHolders
Q4 202222,000$195.1K<0.1%00.0%UnchangedHolders
Q3 202222,000$269.0K0.1%00.0%UnchangedHolders
Q2 202222,000$260.0K0.1%+1,000+4.8%AddedHolders
Q1 202221,000$399.0K0.1%+1,250+6.3%AddedHolders
Q4 202119,750$524.0K0.1%00.0%UnchangedHolders
Q3 202119,750$811.0K0.1%−1,300−6.2%ReducedHolders
Q2 202121,050$1.19M0.2%+1,300+6.6%AddedHolders
Q1 202119,750$830.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.